Genzyme

Ron Branning has been appointed senior vice president of Global Product Quality, Genzyme. In this role, he will ensure the quality of all Genzyme products manufactured at 17 sites around the world. Mr. Branning will report to Genzyme executive vice president David Meeker, M.D., and chief executive officer, Henri Termeer.

“We are committed to the highest standards of drug and device quality for patients,” said Mr. Termeer. “Ron Branning is a recognized industry leader in ensuring product quality, and we look forward to adding his experience to our corporate leadership team. Bringing in new senior leaders such as Ron is a fundamental component of our plan to renew and strengthen our manufacturing organization.”

Prior to joining the company, Mr. Branning led the quality and compliance functions at Gilead Sciences, where he was corporate vice president of Quality and Compliance, and chief compliance officer. He has also held senior quality leadership positions at Genentech, Aventis Behring, and Somatogen (Baxter).